HU-014
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HU-014, covering 2018-04-12 to 2023-08-01. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb [Phase 3]